TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Orifarm Generics AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
586,893
|
461,376
|
482,751 |
Financial expenses |
285
|
458
|
1,045 |
Earnings before taxes |
11,478
|
12,065
|
11,590 |
EBITDA |
10,271
|
8,074
|
12,024 |
Total assets |
152,281
|
104,653
|
77,939 |
Current assets |
145,487
|
99,256
|
72,860 |
Current liabilities |
121,101
|
77,310
|
59,563 |
Equity capital |
31,180
|
27,343
|
18,376 |
- share capital |
101
|
95
|
98 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
20.5%
|
26.1%
|
23.6% |
Turnover per employee |
195,631
|
153,792
|
160,917 |
Profit as a percentage of turnover |
2.0%
|
2.6%
|
2.4% |
Return on assets (ROA) |
7.7%
|
12.0%
|
16.2% |
Current ratio |
120.1%
|
128.4%
|
122.3% |
Return on equity (ROE) |
36.8%
|
44.1%
|
63.1% |
Change turnover |
92,779
|
-6,865
|
158,590 |
Change turnover % |
19%
|
-1%
|
49% |
Chg. No. of employees |
0
![]() |
0
|
3 |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.